Expandable support device and method of use

Information

  • Patent Grant
  • 11141208
  • Patent Number
    11,141,208
  • Date Filed
    Wednesday, October 29, 2008
    15 years ago
  • Date Issued
    Tuesday, October 12, 2021
    2 years ago
Abstract
An expandable support device for tissue repair is disclosed. The device can be used to repair hard or soft tissue, such as bone. The expandable support device can have interconnected struts. A method of repairing tissue is also disclosed. The expandable support device can be inserted into a damaged bone and radial expanded. The radial expansion of the expandable support device struts can cause the struts to cut mechanically support and/or the bone.
Description
BACKGROUND OF THE INVENTION
1. Field of the Invention

This invention relates to devices for providing support for biological tissue, for example to repair spinal compression fractures, and methods of using the same.


BRIEF SUMMARY OF THE INVENTION

An expandable support device for performing completely or partially implantable spinal repair is disclosed. The device has a first strut and a second strut attached to, and/or integral with, the first strut. The first strut is substantially deformable. The second strut can be substantially inflexible.


The device can be configured to expand in a radial direction during deployment in a bone. The device can be configured to contract in a longitudinal direction during deployment in a bone.


An expandable support device for repairing damaged bone is disclosed. The expandable support device can have a longitudinal axis. The expandable support device can have a first strut having a first strut cross-section. The expandable support device can have a second strut attached to, and/or integral with, the first strut. The first strut can be substantially deformable. The first strut cross-section can be configured to encourage bone growth toward the longitudinal axis.


The expandable support device can have a bone growth material. The first strut can have the bone growth material. The first strut can be coated with the bone growth material. The bone growth material can circumferentially surround the first strut cross-section.


The first strut can have a first strut first side closer to the longitudinal axis and a first strut second side farther from the longitudinal axis than the first strut first side, and the bone growth material can be on the first strut first side. The first strut second side can be substantially uncoated with the bone growth material.


The first strut cross-section can have a needle tip. The first strut cross-section can have a chisel tip. The first strut can have a thread extending radially therefrom. The first strut can have a longitudinal vane extending radially therefrom.


An apparatus for deploying and retrieving an expandable support device is a bone is disclosed. The apparatus can have a deployment rod. The deployment rod can have an expandable support device engager. The apparatus can have a retrieval sheath translatably slidable with respect to the deployment rod. The retrieval sheath can be configured to radially compress the expandable support device.


A method of retrieving a deployed expandable support device from a bone is disclosed. The method can include holding the expandable support device. The method can include translating a sheath over the expandable support device. Translating the sheath can include translating a rigid sheath. Holding can include holding a first end of the expandable support device. Translating can include radially compressing the expandable support device. The method can include translating the expandable support device out of the bone.


A method of deploying an expandable support device having a radius in a bone is disclosed. The method can include positioning the expandable support device in the bone. The method can also include radially expanding the expandable support device through the bone. The method can also include creating track voids. The method can also include deploying a material into the track voids, wherein the material encourages bone growth.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of a variation of the expandable support device in a radially expanded configuration.



FIG. 2 is a side view of a variation of the expandable support device in a radially compressed configuration.



FIG. 3 is a rear view of the variation of the expandable support device of FIG. 2 in a radially compressed configuration.



FIG. 4 is a perspective view of the variation of the expandable support device of FIG. 2 in a radially compressed configuration.



FIG. 5 is a close-up view of section AA of FIG. 2.



FIG. 6 is a close-up view of section AB of FIG. 2.



FIG. 7 illustrates a variation of the expandable support device in a radially contracted configuration.



FIG. 8 illustrates a variation of a cell of the expandable support device of FIG. 7.



FIG. 9 illustrates a variation of the expandable support device in a radially expanded configuration.



FIG. 10 illustrates a variation of a cell of the expandable support device of FIG. 9.



FIGS. 11-13 illustrate cross section B-B of various variations of the expandable support device.



FIG. 14 illustrates cross-section C-C of the variation of the expandable support device in FIG. 13.



FIG. 15 is a side view of a variation of the distal attachment element.



FIG. 16 is a front view of a variation of the distal attachment element.



FIG. 17 illustrates a variation of cross-section AC-AC of FIG. 15.



FIG. 18 is a perspective view of a variation of cross-section AC-AC of FIG. 15.



FIG. 19 is a side view of a variation of the proximal attachment element.



FIG. 20 is a rear view of a variation of the proximal attachment element.



FIG. 21 illustrates a variation of cross-section AD-AD of FIG. 19.



FIG. 22 is a perspective view of a variation of cross-section AD-AD of FIG. 19.



FIGS. 23 through 38 illustrate various variations of section A-A of FIG. 9.



FIG. 39 illustrates various methods for deploying the expandable support device.



FIG. 40 illustrates a variation of a method of deploying the expandable support device with a deployment tool.



FIG. 41 illustrates the variation of FIG. 40 with the deployment tool in a partially disassembled configuration.



FIGS. 42 and 43 illustrate cross-section D-D of a variation of a method for radially expanding the expandable support device of FIG. 40.



FIGS. 44 through 46 illustrate a variation of the method of retrieving the expandable support device.



FIG. 47 illustrates a variation of the deployment tool with the expandable support device removed from the vertebra.



FIGS. 40, 41, and 44 through 47 illustrate the vertebra with a partial ventral sagittal cut-away for illustrative purposes.



FIGS. 48 through 52 illustrate longitudinal cross-sectional views (similar to sectional view D-D) of a variation for the deployment and recovery of a variation of the expandable support device.



FIG. 53 illustrates a variation of the expandable support device loaded on a variation of the deployment tool.



FIG. 54 illustrate cross-sections E-E and F-F of the deployment rod and expandable support device, respectively, of FIG. 53 in aligned unlocked configurations.



FIG. 55 illustrate cross-sections E-E and F-F of the deployment rod and expandable support device, respectively, of FIG. 53 in aligned locked configurations.



FIGS. 56 and 57 illustrate variations of explants of the expandable support device with bone.



FIG. 58 is a close-up view of section H of FIG. 56.



FIGS. 59 through 61 illustrate various variations of cross-section G-G of FIG. 57.






FIGS. 1, 40, 51, 45, 47, 56 and 57, are shown with exemplary length scales labeled in 10 mm increments and tabbed in ½ mm and 1 mm increments.


Dimensions shown in FIGS. 15, 16, 17, 19 and 21 are merely examples. All dimensions can be from about 25% to about 400% of the dimensions shown in the figures, more narrowly from about 75% to about 125% of the dimensions shown in the figures.


DETAILED DESCRIPTION


FIG. 1 illustrates an expandable support device 2 in a radially expanded and longitudinally contracted configuration. The expandable support device 2 can be configured to be deployed in a treatment site, such as a bone, to provide mechanical support, for example to treat compression or other fractures or other structural bone failures. The expandable support device 2 can have a radially contracted and longitudinally expanded configuration, for example before deployment into a treatment site. The expandable support device 2 can have a radially expanded and longitudinally contracted configuration, for example after deployment into the treatment site.


The expandable support device 2 can have a longitudinal axis 4. The expandable support device 2 can have a distal port 6 at a longitudinally distal end and a proximal port 8 at a longitudinally proximal end. The expandable support device 2 can have a device radial side 10. The device side 10 can be substantially the surface defined by the cells 12 and pores 14, and for example, can exclude the proximal port 8 and the distal port 6.


The expandable support device 2 can have a number of struts 16 connected at joints 18. The struts 16 can be rigid and/or flexible. The struts 16 can be deformable and/or resilient. The joints 18 can be rigid and/or flexible. The joints 18 can be deformable and/or resilient.


The struts 16 and joints 18 can form enclosed shapes, such as cells 12. The cell 12 can dynamically act as a four-bar system (e.g., if the cell has four struts), five-bar system (e.g., if the cell has five struts), or another closed dynamic system correlating with the number of struts 16 and joints 18 of the cell.


The interior area of each cell can be a pore 14. The pores 14 can be open to the radial center of the expandable support device 2. The pores 14 can be substantially unobstructed. The pores 14 can encourage tissue (e.g., bone) growth toward the lumen or longitudinal channel of the expandable support device 2.


The device side can have a device side area 10. The radially (e.g., with respect to the longitudinal axis) external area joints 18 and struts 16 can be a solid surface area. The radially (e.g., with respect to the longitudinal axis) external area of the pores 14 can be a pore area. The ratio of the pore area to the device side area can be a pore ratio. With the expandable support device 2 in a radially expanded configuration, the pore ratio can be from about 20% to about 99%, more narrowly from about 50% to about 98%, yet more narrowly from about 75% to about 95%, for example about 80% or about 85% or about 90%.


Additional exemplary variations, features, elements and methods of use of the expandable support device and tools for deploying the expandable support device are described in PCT Patent Application Ser. Nos. PCT/US05/034115 filed 21 Sep. 2005; PCT/US05/034742 filed 27 Sep. 2005; PCT/US05/034728 filed 27 Sep. 2005; PCT/US2005/037126 filed 12 Oct. 2005; and U.S. Provisional Patent Application Nos. 60/675,543 filed 27 Apr. 2005; 60/741,201 filed 1 Dec. 2005; 60/741,197 filed 1 Dec. 2005; 60/751,882 filed 19 Dec. 2005; 60/675,512 filed 27 Apr. 2005; 60/752,180 filed 19 Dec. 2005; 60/699,577 filed 14 Jul. 2005; 60/699,576 filed 14 Jul. 2005; 60/754,492 filed 28 Dec. 2005; 60/751,390 filed 15 Dec. 2005; 60/752,186 filed 19 Dec. 2005; 60/754,377 filed 27 Dec. 2005; 60/754,227 filed 28 Dec. 2005; 60/752,185 filed 19 Dec. 2005; and 60/752,182 filed 19 Dec. 2005; all of which are incorporated by reference herein in their entireties.



FIGS. 2, 3 and 4 illustrate that a distal end of the expandable support device 2 can be attached to and/or integral with a distal releasable attachment element 20. The proximal end of the expandable support device 2 can be attached to and/or integral with a proximal releasable attachment element 22.



FIG. 5 illustrates that the distal releasable attachment element 20 can be fixedly or removably attached to the expandable support device 2 at one or more attachment points 24. The attachment points 24 can be welds, press fits, adhesive, integrated elements, or combinations thereof.



FIG. 6 illustrates that the proximal releasable attachment element 22 can be fixedly or removably attached to the expandable support device 2 at one or more attachment points 24. The proximal releasable attachment element 22 can have a varying outer diameter along its length. The outer diameter of the proximal releasable attachment element 22 act as an interface, for example to be engaged by a deployment tool.



FIG. 7 illustrates that the expandable support device 2 can have a radially contracted configuration. The expandable support device 2 can have a contracted diameter 26 and an expanded length 28. The expandable support device 2 can have a substantially cylindrical shape.



FIG. 8 illustrates that the cell 12 can have at least one longitudinal cell angle 30. The longitudinal cell angle 30 can be the angle formed between a first strut 32 and a second strut 34. The longitudinal cell angle 30 can face in a substantially parallel, or otherwise aligned, direction to the longitudinal axis 4.


The cell 12 can have at least one transverse cell angle 36. The transverse cell angle 36 can be the angle formed between the first strut 32 and a third strut 38. The transverse cell angle 36 can face in a substantially perpendicular or otherwise misaligned direction to the longitudinal axis 4. The transverse cell angle 36 can face in a substantially perpendicular or otherwise misaligned direction to the longitudinal cell angle 30.



FIG. 9 illustrates that the expandable support device 2 can have a radially expanded configuration. The expandable support device 2 can have an expanded diameter 40 and a contracted length 42. The expanded diameter 2 can be greater than the contracted diameter 26. The contracted length 42 can be less than the expanded length 28. The expandable support device 2 can have a substantially spherical, toroid or cubical shape.



FIG. 10 illustrates that transverse cell angle 36 in the cell 12 from the expandable support device 2 having the radially expanded configuration can be smaller than the cell angle 36 in the cell from the expandable support device 2 having the radially contracted configuration. The longitudinal cell angle 30 in the cell 12 from the expandable support device 2 having the radially expanded configuration can be larger than the cell angle 36 in the cell 12 from the expandable support device 2 having the radially contracted configuration.



FIG. 11 illustrates that the expandable support device 2 can have releasable attachment elements at the distal and/or proximal ends. For example, the expandable support device 2 can have distal device threads 44 and/or proximal device threads 46. The device mid-length section 48 can be bare of threads. The releasable attachment elements can be controllably removably attached to a deployment tool and/or the remainder of the expandable support device 2.



FIG. 12 illustrates that the device threads 50 can be continuous and/or substantially continuous from the proximal to the distal end (i.e., including the device mid-length section 48) of the expandable support device 2.



FIGS. 13 and 14 illustrates that the releasable attachment element, such as the proximal releasable attachment element 22, can be one or more device keys 52. The device keys 52 can have device key distal ends 54. The device key distal ends 54 can protrude in the distal direction and, for example can be sharpened. Device key ports 56 can be angularly between the device keys 52. The releasable attachment devices can be threads, keys, tabs, luers, or combinations thereof.



FIGS. 15, 16, 17 and 18 illustrate that the distal releasable attachment element 20 can have an internal channel 58. The internal channel 58 can have an internal channel diameter 59. The internal channel diameter 59 can be from about 1 mm (0.4 in.) to about 3 mm (0.1 in.), for example about 1.99 mm (0.0785 in.)


The distal releasable attachment element 20 can have distal device threads 44 (shown in FIG. 18).


The distal releasable attachment element 20 can have a sharpened distal end. The sharpened distal end can be used, for example, to push through bone during use. The sharpened distal end can have a sharpened distal end angle 61. The sharpened distal end angle 61 can be from about 20° to about 70°, for example about 45°.


The distal releasable attachment element 20 can have a distal releasable attachment element length 63. The distal releasable attachment element length 63 can be from about 13 mm (0.051 in.) to about 5 mm (0.2 in.), for example about 2.92 mm (0.115 in.).


The distal releasable attachment element 20 can have a distal releasable attachment element outer diameter 65. The distal releasable attachment outer diameter 65 can be from about 2.5 mm (0.098 in.) to about 10 mm (0.4 in.), for example about 4.78 mm (0.188 in.).


The distal releasable attachment element 20 can have an inner chamfer 67. The inner chamfer 67 can have an angle of about 45° from the adjacent sides and can have a length of about 0.2 mm (0.009 in.).



FIGS. 19, 20, 21 and 22 illustrate that the proximal releasable attachment element 22 can have the internal channel 58. The distal releasable attachment element 20 can have distal device threads 44 (shown in FIG. 18). The distal releasable attachment element 20 can have an engagable (e.g., lipped or notched) proximal end. The engagable proximal end can be configured, for example, to releasably engage a deployment tool.



FIG. 23 illustrates that the struts 16 can define a circular or oval cross-section of the expandable support device 2 in a given cross-section A-A. The pores 14 can have pore angles 60 with respect to the longitudinal axis 4 in cross-section, as shown. The pore angles 60 can vary around the cross-section of the expandable support device 2 (i.e., as the pores get closer to distal and proximal joints, the pore angles approach zero). The struts 16 can have uniform (as shown) or various cross-sectional configurations. The struts 16 can have substantially circular cross-sections, as shown in FIG. 10.



FIG. 24 illustrates that the struts 16 can form a square or rectangular cross-section of the expandable support device 2 in a given cross-section A-A. One or more of the struts 16 can have markers 62, such as radiopaque and/or echogenic markers. The markers 62 can be unique for each strut 16. For example, the markers 62 can identify the deployment orientation, as shown (e.g., arrows pointing in the up direction for deployment, with the top strut's marker showing a top arrow; the left strut's marker showing an arrow with only a left arrow-end; the right strut's marker showing an arrow with only a left arrow-end; and the bottom strut's marker showing an arrow with the arrowhead near the bottom of the arrow).



FIG. 25 illustrates that the struts 16 can have substantially square or rectangular cross-sectional configurations. The struts 16 and joints 14 (not shown, and understood to be substantially represented when describing the struts in cross-sections A-A) can have first rectilinear axes 64. The first rectilinear axes 64 can substantially or completely intersect the longitudinal axis 4 in a given cross-section A-A. Expandable support devices 2 that do not have circular or ovular transverse cross-sections (i.e., the shapes defined by the struts and pores shown in cross-section A-A), such as square, rectangular, triangular transverse cross-sections, or combinations thereof, can have one or more struts 16 with rectilinear axes 64 that do not substantially intersect the longitudinal axis 4 in a given cross-section A-A.



FIG. 26 illustrates that the struts 16 and joints 14 (not shown) can have diametric or diagonal axes 66 in a given cross-section A-A. The diametric or diagonal axes 66 can substantially or completely intersect the longitudinal axis 4. Expandable support devices 2 that do not have circular or ovular transverse cross-sections (i.e., the shapes defined by the struts and pores shown in cross-section A-A), such as square, rectangular, triangular transverse cross-sections, or combinations thereof, can have one or more struts 16 with diametric or diagonal axes 66 that do not substantially intersect the longitudinal axis 4 in a given cross-section A-A. The struts 16 can have square or rectangular cross-sectional configurations.



FIG. 27 illustrates that the struts 16 and joints 14 (not shown) can have rectangular or oval (as shown) cross-sectional configurations or other cross-sectional configurations with primary and secondary axes. The oval cross-sections can each have a major (i.e., primary) axis 68. The oval cross-sections can each have a minor (i.e., secondary) axis 70 in a given cross-section A-A. The major axes 68 can substantially or completely intersect the longitudinal axis 4. The minor axes 70 can substantially or completely intersect the longitudinal axis 4. Expandable support devices 2 that do not have circular or ovular transverse cross-sections (i.e., the shapes defined by the struts and pores shown in cross-section A-A), such as square, rectangular, triangular transverse cross-sections, or combinations thereof, can have one or more struts 16 with major 68 and/or minor axes 70 that do not substantially traverse the longitudinal axis 4 in a given cross-section A-A.



FIG. 28 illustrates that the struts 16 and joints 14 (not shown) can have triangular (e.g., diagonal, right, isosceles, equilateral) cross-sectional configurations. The triangular configurations can each have the major axis 68.



FIG. 29 illustrates that the struts 16 and joints 14 (not shown) can have needle tips 72, for example with a triangular configuration cross-sectional configuration. The needle tip 72 can have a first needle side 74 and a second needle side 76. One or both needle sides can be concave inward. The needle tip 72 can have a needle tip angle from about 0.1° to about 30°, more narrowly from about 0.5° to about 25°, yet more narrowly from about 2° to about 20°, for example about 5° or about 10° or about 15°.



FIG. 30 illustrates that the struts 16 and joints 14 (not shown) can each have a first needle tip 78 pointed radially outward, and a second needle tip 80 pointed radially inward. The major axis 68 can be the major axis for the first and second needle tips 78, 80.



FIG. 31 illustrates that the struts 16 and joints 14 (not shown) can have a first tip 82 and a second tip 84 along the major axis 68. The struts 16 can be of nominal or otherwise substantially no thickness in directions other than the major axis 68.



FIG. 32 illustrates that the struts 16 and joints 14 (not shown) can have a nail-like configuration. The struts 16 can have a tip 86 running on the major axis 68. The struts 16 can have a head 88, for example, at about a 90° angle to the tip 86 and/or to the major axis 68.



FIG. 33 illustrates that the struts 16 and joints 14 (not shown) can have chisel tips 90. The struts 16 can have quadrilateral (e.g., bicentric quadrilateral, cyclic quadrilateral, orthocentric quadrilateral, rational quadrilateral), parallelogram (e.g., medial parallelogram), rhombus (e.g., golden rhombus), kite, lozenge, trapezoid (e.g., isosceles trapezoid), tetrahedron cross-sectional configuration or combinations thereof.



FIG. 34 illustrates that the struts 16 and joints 14 (not shown) can have randomly-shaped surface 92 configurations. The randomly-shaped surface 92 configurations can have an irregular surface defined by a random or quasi-random configuration.



FIG. 35 illustrates that the struts 16 can have a textured (e.g., non-randomly surfaced) surface 94 configuration. For example, the textured surface 94 configuration can have a knurled, convex or concave dimpled or bumped, transversely and/or longitudinally and/or diagonally checkered or grooved (as shown), or brushed configuration, or combinations thereof.



FIG. 36 illustrates that the struts 16 can each have one or more threads and/or longitudinal vanes 96 attached to or integral therewith. The threads and/or vanes 96 can extend radially toward the longitudinal axis 4. The threads and/or vanes 96 can have a coating or be made partially or completely from any material listed herein, such as cements and/or fillers and/or glues (e.g., bone morphogenic protein, morselized bone, additional examples listed infra), such as for soliciting or otherwise encouraging bone growth. The threads and/or vanes 96 can be flexible or rigid. The threads and/or vanes 96 can be resilient and/or deformable. The threads and/or vanes 96 can be made in whole or part from a bioresorbable, bioabsorbable or biodegradable material. The various threads and/or vanes 96 can have uniform or variable lengths.



FIG. 37 illustrates that the struts 16 can be wholly (as shown) or partially coated and/or otherwise covered by a coating and/or matrix 98 of any material listed herein. FIG. 38 illustrates that the struts 16 can be coated and/or be otherwise covered by a material listed herein on the side of the strut 16 facing the longitudinal axis 4. The side of the strut 16 not facing the longitudinal axis 4 can have no coating neither/nor be otherwise covered by a material other than the material of the original non-coated/covered strut.


Any or all elements of the expandable support device 2 and/or deployment tool and/or other devices or apparatuses described herein can be made from, for example, a single or multiple stainless steel alloys, nickel titanium alloys (e.g., Nitinol), cobalt-chrome alloys (e.g., ELGILOY® from Elgin Specialty Metals, Elgin, Ill.; CONICHROME® from Carpenter Metals Corp., Wyomissing, Pa.), nickel-cobalt alloys (e.g., MP35N® from Magellan Industrial Trading Company, Inc., Westport, Conn.), molybdenum alloys (e.g., molybdenum TZM alloy, for example as disclosed in International Pub. No. WO 03/082363 A2, published 9 Oct. 2003, which is herein incorporated by reference in its entirety), tungsten-rhenium alloys, for example, as disclosed in International Pub. No. WO 03/082363, polymers such as polyethylene teraphathalate (PET), polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, aromatic polyesters, such as liquid crystal polymers (e.g., Vectran, from Kuraray Co., Ltd., Tokyo, Japan), ultra high molecular weight polyethylene (i.e., extended chain, high-modulus or high-performance polyethylene) fiber and/or yarn (e.g., SPECTRA® Fiber and SPECTRA® Guard, from Honeywell International, Inc., Morris Township, N.J., or DYNEEMA® from Royal DSM N.V., Heerlen, the Netherlands), polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), polyether ketone (PEK), polyether ether ketone (PEEK), poly ether ketone ketone (PEKK) (also poly aryl ether ketone ketone), nylon, polyether-block co-polyamide polymers (e.g., PEBAX® from ATOFINA, Paris, France), aliphatic polyether polyurethanes (e.g., TECOFLEX® from Thermedics Polymer Products, Wilmington, Mass.), polyvinyl chloride (PVC), polyurethane, thermoplastic, fluorinated ethylene propylene (FEP), absorbable or resorbable polymers such as polyglycolic acid (PGA), poly-L-glycolic acid (PLGA), polylactic acid (PLA), poly-L-lactic acid (PLLA), polycaprolactone (PCL), polyethyl acrylate (PEA), polydioxanone (PDS), and pseudo-polyamino tyrosine-based acids, extruded collagen, silicone, zinc, echogenic, radioactive, radiopaque materials, a biomaterial (e.g., cadaver tissue, collagen, allograft, autograft, xenograft, bone cement, morselized bone, osteogenic powder, beads of bone) any of the other materials listed herein or combinations thereof. Examples of radiopaque materials are barium sulfate, zinc oxide, titanium, stainless steel, nickel-titanium alloys, tantalum and gold.


Any or all elements of the expandable support device 2 and/or deployment tool and/or other devices or apparatuses described herein, can be, have, and/or be completely or partially coated with agents and/or a matrix a matrix for cell ingrowth or used with a fabric, for example a covering (not shown) that acts as a matrix for cell ingrowth. The matrix and/or fabric can be, for example, polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or combinations thereof.


The expandable support device 2 and/or deployment tool and/or elements of the expandable support device 2 and/or elements of the deployment tool and/or other devices or apparatuses described herein and/or the fabric can be filled, coated, layered and/or otherwise made with and/or from cements, fillers, glues, and/or an agent delivery matrix known to one having ordinary skill in the art and/or a therapeutic and/or diagnostic agent. Any of these cements and/or fillers and/or glues can be osteogenic and osteoinductive growth factors.


Examples of such cements and/or fillers includes bone chips, demineralized bone matrix (DBM), calcium sulfate, coralline hydroxyapatite, biocoral, tricalcium phosphate, calcium phosphate, polymethyl methacrylate (PMMA), biodegradable ceramics, bioactive glasses, hyaluronic acid, lactoferrin, bone morphogenic proteins (BMPs) such as recombinant human bone morphogenetic proteins (rhBMPs), other materials described herein, or combinations thereof.


The agents within these matrices can include any agent disclosed herein or combinations thereof, including radioactive materials; radiopaque materials; cytogenic agents; cytotoxic agents; cytostatic agents; thrombogenic agents, for example polyurethane, cellulose acetate polymer mixed with bismuth trioxide, and ethylene vinyl alcohol; lubricious, hydrophilic materials; phosphor cholene; anti-inflammatory agents, for example non-steroidal anti-inflammatories (NSAIDs) such as cyclooxygenase-1 (COX-1) inhibitors (e.g., acetylsalicylic acid, for example ASPIRIN® from Bayer A G, Leverkusen, Germany; ibuprofen, for example ADVIL® from Wyeth, Collegeville, Pa.; indomethacin; mefenamic acid), COX-2 inhibitors (e.g., VIOXX® from Merck & Co., Inc., Whitehouse Station, N.J.; CELEBREX® from Pharmacia Corp., Peapack, N.J.; COX-1 inhibitors); immunosuppressive agents, for example Sirolimus (RAPAMUNE®, from Wyeth, Collegeville, Pa.), or matrix metalloproteinase (MMP) inhibitors (e.g., tetracycline and tetracycline derivatives) that act early within the pathways of an inflammatory response. Examples of other agents are provided in Walton et al, Inhibition of Prostoglandin E2 Synthesis in Abdominal Aortic Aneurysms, Circulation, Jul. 6, 1999, 48-54; Tambiah et al, Provocation of Experimental Aortic Inflammation Mediators and Chlamydia Pneumoniae, Brit. J. Surgery 88 (7), 935-940; Franklin et al, Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis, Brit. J. Surgery 86 (6), 771-775; Xu et al, Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium, J. Biological Chemistry 275 (32) 24583-24589; and Pyo et al, Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) Suppresses Development of Experimental Abdominal Aortic Aneurysms, J. Clinical Investigation 105 (11), 1641-1649 which are all incorporated by reference in their entireties.


METHOD OF USE


FIG. 39 illustrates that a first deployment tool 100 can enter through the subject's back. The first deployment tool 100 can enter through a first incision 102 in skin 104 on the posterior side of the subject near the vertebral column 106. The first deployment tool 100 can be translated, as shown by arrow 108, to position a first expandable support device 110 into a first damage site 112. The first access port 114 can be on the posterior side of the vertebra 116.


A second deployment tool 118 can enter through a second incision 120 (as shown) in the skin 104 on the posterior or the first incision 102. The second deployment tool 118 can be translated through muscle (not shown), around nerves 122, and anterior of the vertebral column 106. The second deployment tool 118 can be steerable. The second deployment tool 118 can be steered, as shown by arrow 124, to align the distal tip of the second expandable support device 126 with a second access port 128 on a second damage site 130. The second access port 128 can face anteriorly. The second deployment tool 118 can translate, as shown by arrow 132, to position the second expandable support device 126 in the second damage site 130.


The vertebra 116 can have multiple damage sites 112, 130 and expandable support devices 2 deployed therein. The expandable support devices 2 can be deployed from the anterior, posterior, both lateral, superior, inferior, any angle, or combinations of the directions thereof.


As shown in applications incorporated by reference herein, the expandable support device 2 can be inserted in the vertebra 116 in a radially contracted configuration. The expandable support device 2 can then be radially expanded.



FIG. 40 illustrates the expandable support device 2 in a partially deployed, radially expanded configuration in the vertebra 116. The expandable support device 2 can be removably attached to the deployment tool 134. The deployment tool 134 can have a deployment rod sheath 136, as shown. The expandable support device 2 can be attached to a deployment rod and/or the deployment rod sheath 136.



FIG. 41 illustrates FIG. 40 with the deployment tool 134 partially disassembled for illustrative purposes. The deployment tool 134 can have a recovery sheath 138. The recovery sheath 138 can be slidably attached over the deployment rod and/or the deployment rod sheath 136. The recovery sheath 138 can be hollow cylinder. The recovery sheath 138 can be translatably controlled by the deployment tool 134. The deployment rod sheath 136 can be slidably or fixedly attached to the deployment rod and/or the remainder of the deployment tool 134.



FIG. 42 illustrates that a deployment tool 134 can have a distal tool head 140 at the distal end of a distal tool shaft 142. The distal tool shaft 142 can be removably attached to the distal end of the expandable support device 2 (e.g. interference fit and/or threadably attached). The deployment tool 134 can have an engagement element 144 that can be removably attached (e.g., threadably attached and/or interference fit) to the proximal end of the expandable support device 2. For example, one or more struts 16 at the proximal end of the expandable support device 2 can be releasably compressed between the engagement element 144 and a proximal anvil 146 that can be attached to or integral with the deployment rod 148.


The distal tool shaft 142 can be translated proximally, as shown by arrow 150. The distal tool head 140 and the proximal anvil 146 can longitudinally compress, as shown by arrow 152, the expandable support device 2. The expandable support device 2 can then radially expand, as shown by arrow 154.



FIG. 43 illustrates that the distal tool head 140 can be removably attached (e.g., unscrewable, or unlockable—as a key, or retractable (e.g., rotatably, or otherwise compressably or condensably)) attached to the distal tool shaft 142. The distal tool head 140 can be retracted and the distal tool shaft 142 can be translated out of the expandable support device, as shown by arrow 150.



FIGS. 44 and 45 illustrate that the expandable support device 2 can be in a radially expanded configuration in the vertebra. The expandable support device 2 can be attached to the deployment tool 134 (e.g., never released during deployment or released and re-attached/re-engaged). The expandable support device 2 can be in an incorrect location, improperly radially expanded, or otherwise desirous of being removed, repositioned, or otherwise redeployed. The recovery sheath 138 can be translated, as shown by arrow 156, toward and onto the expandable support device 2. The expandable support device 2, substantially other than the recovery sheath 138, can be substantially stationary with respect to the expandable support device 2. The recovery sheath 138 can begin to radial compress, as shown by arrows 158, the expandable support device 2.



FIG. 46 illustrates that the recovery sheath 138 can be additionally translated, as shown by arrow 156, over the expandable support device 2. The expandable support device 2 can radially contract, as shown by arrows 158, for example into a substantially radially contracted configuration. The deployment tool 134 can then by translated, as shown by arrow 160, away from the vertebra 116. The deployment tool 134 can reposition the expandable support device 2 and retract the recovery sheath 138, and for example radially expand the expandable support device 2 in the vertebra 116 (e.g., with or without removing the expandable support device from the vertebra).



FIG. 47 illustrates that the deployment tool 134 can completely remove the expandable support device 2 from the vertebra 116. The same or a different expandable support device 2 can then be deployed into the vertebra 116.



FIG. 48 illustrates that the expandable support device 2 can be releasably attached to the deployment tool 134. The deployment tool 134 can have the deployment rod 148 extending from the deployment rod sheath 136. The deployment tool 148 can have distal rod threads 162. The distal rod threads 162 can be releasably (e.g., rotatably) attached to the distal device threads 44. The deployment rod 148 can have proximal rod threads 164 between the distal rod threads 162 and the proximal device threads 46. The deployment tool 134 can have a deployment rod sheath 136. The deployment rod sheath 136 can abut, interference fit or otherwise attach to the proximal end of the expandable support device 2.



FIG. 49 illustrates that the deployment rod 148 can be forcibly proximally translated, as shown by arrow 166. The expandable support device 2 can then be longitudinally compressed, as shown by arrow 168, between the distal device threads 44 and the deployment rod sheath 136 and/or other proximal attachment device (not shown). The expandable support device 2 can radially expand, as shown by arrows 170, for example due to the longitudinal compression 152.



FIG. 50 illustrates that, with the expandable support device 2 in a radially expanded configuration, the deployment rod 148 can be proximally translated, as shown by arrow 166. The translation of the deployment rod can, for example, be due to rotation of the deployment rod 148, as shown by arrow 172, and the threading of distal rod threads 162 through the distal device threads 44.


The proximal rod threads 164 can thread into the proximal device threads 46. If the placement and configuration of the expandable support device 2 is satisfactory, the proximal rod threads 164 can be rotatably removed from the proximal device threads 46. The deployment device can then be removed entirely. If the placement and configuration of the expandable support device 2 is not satisfactory, the expandable support device 2 can be radially contracted and removed from the treatment site, as described infra.



FIG. 51 illustrates that the recovery sheath 138 can be translated, as shown by arrow 156, toward the expandable support device 2, and/or the expandable support device 2 can be translated (e.g., via translation of the attached deployment rod 148) toward the recovery sheath 138.



FIG. 52 illustrates that the recovery sheath 138 can be translated onto the expandable support device 2, as shown by arrow 171, and/or the expandable support device 2 (e.g., via translation of the attached deployment rod 148) can be translated, as shown by arrow 173, into the recovery sheath 138 and/or the expandable support device 2 can be translated toward the recovery sheath 138. As the expandable support device 2 is translated into the recovery sheath 138, the expandable support device 2 can be radially contracted, as shown by arrows 174. When the expandable support device 2 is sufficiently radially contracted 174 and/or in the recovery sheath 138, the deployment tool 134 and the expandable support device 2 can be removed from the treatment site.



FIGS. 53 and 54 illustrates that the deployment tool 134 can have a deployment rod key 176. The deployment rod key 176 can be configured to interference fit against the device key 52 when the expandable support device 2 and the deployment tool 134 are in a locked configuration, as shown in FIG. 54. As shown in FIG. 55, when the deployment rod 148 is rotated into an unlocked configuration, as shown by arrow, the deployment rod key 176 can be configured to translate through the device key port 56, and the device key 52 can translate through the deployment rod key port 178.


After being radially expanded, the expandable deployment device 2 can be detached from the deployment tool 134 by turning the deployment rod 148 to the unlocked configuration, and then proximally translating the deployment rod 148. The expandable support device 2 can be radially contracted into the recovery sheath 138 by turning the deployment rod 148 to the locked configuration, and then distally translating the recovery sheath 138 while holding and/or proximally translating the deployment rod 148.



FIGS. 56 through 58 illustrate an expandable support device 2 explanted from a bone 180 can have bone substantially surrounding the struts 16. The bone 180 can pass through the pores 14. The struts 16 and joints 18 can be forced through the bone 180 during deployment of the expandable support device 2 in the bone 180. The bone 180 can grow around the struts 16 and joints 18 after deployment.



FIG. 59 illustrates the struts 16 can deploy through the bone 180. When the struts 16 expand (e.g., during radial expansion of the expandable support device 170), the struts 16 can create voids or struts tracks 182. The struts 16 can have a wide enough dimension transverse to the direction of radial expansion that the strut tracks 182 can be large enough to access and fill partially or completely with any material (e.g., BMP, bone cement, morselized bone, bone growth matrix). The struck tracks 182 can also be filled partially or completely with the threads or longitudinal vanes 96.



FIG. 60 illustrates that the strut 16 can be configured to leave a large or small strut track 182 during radial expansion of the expandable support device 170. The width of the track 182 can correspond to the strut width. The struts 16 can have a narrow dimension transverse to the direction of radial expansion. For example, the strut 16 can have a diamond-shaped cross-section with a longer dimension in the radial dimension than the angular dimension (i.e., the strut dimension transverse to the radial dimension). The visco-elastic nature of bone (e.g., cancellous bone and/or cortical bone) can cause the bone to back-fill the tracks 182 as shown in FIG. 60.



FIG. 61 illustrates that the strut 16 can be configured to leave a nominal or no strut track during radial expansion of the expandable support device 170. The struts 16 can have a nominal or otherwise substantially no thickness in the angular dimension (i.e., the strut dimension transverse to the radial dimension).


The expandable support device 2 can also be used for various other medical and non-medical applications: to immobilize and/or stabilize orthopedic trauma, hip fractures and other trauma, clavicle fractures and other trauma, small bones (e.g., carpals, tarsals, talus, other hand, feet and ankle bones) fractures and other trauma, other long bone repair (e.g., internal bone splinting), spinal fusion, use as an intermedullary canal implant to anchor an artificial joint, use as a bone anchor for a tendon repair or ligament implant (e.g., for anterior cruciate ligament repair or replacement), or combinations thereof.


Any elements described herein as singular can be pluralized (i.e., anything described as “one” can be more than one). Any species element of a genus element can have the characteristics or elements of any other species element of that genus. The above-described configurations, elements or complete assemblies and methods and their elements for carrying out the invention, and variations of aspects of the invention can be combined and modified with each other in any combination. All devices, apparatuses, systems, and methods described herein can be used for medical (e.g., diagnostic, therapeutic or rehabilitative) or non-medical purposes.

Claims
  • 1. A method of retrieving a deployed expandable support device from a bone, wherein the deployed expandable support device is in a radially expanded configuration, and wherein the expandable support device has pushed through a portion of the bone, comprising: expanding an expandable length of the expandable support device in the bone, wherein the expandable support device has a circular cross-section before the expanding of the expandable support device in the bone, wherein the expandable length has a first helical ridge extending radially outward relative to a proximal terminal end of the device when the device is in a fully radially contracted configuration, and wherein the expandable length has a second helical ridge extending radially inward when the device is in the fully radially contracted configuration;attaching to the expandable support device, wherein the expandable support device is fixed in the bone at least with the first helical ridge;holding the expandable support device; andtranslating the expandable support device into a sheath, wherein translating the expandable support device comprises longitudinally tensioning the expandable support device and radially contracting the expandable support device, and wherein when the expandable support device is partially translated into the sheath, an outer diameter of a longitudinally medial portion of the expandable support device is greater than a sheath outer diameter.
  • 2. The method of claim 1, wherein the sheath comprises a rigid sheath, and wherein holding comprises holding a first end of the expandable support device, and wherein translating further comprises radially compressing the expandable support device.
  • 3. The method of claim 1, further comprising translating the expandable support device out of the bone, wherein when the device is in the fully radially contracted configuration, a straight axis perpendicular to a longitudinal axis of the device intersects the longitudinal axis of the device, an apex of the first helical ridge, and a surface of the expandable length opposite the apex of the first helical ridge.
  • 4. The method of claim 1, wherein the expandable support device comprises a first cell and a second cell, wherein the device has a first strut having a first portion of the first helical ridge and a second strut having a second portion of the first helical ridge, and wherein when the device is in a fully radially expanded configuration, the first or second portions of the first helical ridge define a radial outermost point of the device.
  • 5. The method of claim 1, wherein expanding the expandable support device in the bone comprises moving the first helical ridge and the second helical ridge through the bone.
  • 6. The method of claim 5, wherein the first helical ridge extends radially outward relative to a longitudinal axis of the device, and wherein the second helical ridge is at the longitudinally medial portion of the expandable support device.
  • 7. The method of claim 5, wherein the second helical ridge extends radially inward relative to a longitudinal axis of the device.
  • 8. The method of claim 1, wherein the expandable support device comprises diamond-shaped cells on a radially outer surface of the device.
  • 9. The method of claim 1, wherein the expandable support device comprises diamond-shaped cells on a radially inner surface of the expandable support device.
  • 10. The method of claim 1, wherein a distal terminal end of the expandable length tapers radially inward.
  • 11. The method of claim 1, wherein when the device is in a contracted configuration, an outer diameter of the proximal terminal end of the device is less than an outer diameter of a longitudinally medial portion of the device.
  • 12. A method of retrieving a deployed expandable support device from a bone, wherein the deployed expandable support device is in a radially expanded configuration, and wherein the expandable support device has pushed through a portion of the bone, comprising: expanding the expandable support device in the bone, wherein the expandable support device has a circular cross-section before the expanding of the expandable support device in the bone, wherein a distal terminal end of the expandable support device tapers radially inward;attaching to the expandable support device, wherein the expandable support device is fixed in the bone at least by pressing a first strut having a first ridge and a second strut having a second ridge of the expandable support device into the bone, wherein the first strut has a first strut first end and a first strut second end, wherein the second strut has a second strut first end and a second strut second end, wherein the first strut second end is connected to the second strut first end, wherein the first strut first end is closer to a proximal terminal end of the device than the second strut first end, wherein the first and second ridges extend radially outward relative to the proximal terminal end of the device when the device is in a radially contracted configuration, wherein the first ridge is a first portion of a helical ridge of the device, wherein the second ridge is a second portion of the helical ridge of the device, wherein when the device is in a fully expanded configuration, the first ridge or the second ridge defines a radial outermost point of the device, and wherein when the device is in a fully contracted configuration, an outer diameter of the proximal terminal end of the device is less than an outer diameter of a longitudinally medial portion of the device, wherein when the device is in the fully contracted configuration, the first strut has a first strut first cross-sectional shape perpendicular to a device longitudinal axis and has a first strut second cross-sectional shape perpendicular to the device longitudinal axis, and wherein the first strut first cross-sectional shape is different than the first strut second cross-sectional shape;holding the expandable support device; andtranslating the expandable support device into a sheath, wherein translating the expandable support device comprises longitudinally tensioning the expandable support device and radially contracting the expandable support device.
  • 13. The method of claim 12, wherein the sheath comprises a rigid sheath, and wherein the holding comprises holding a first end of the expandable support device, wherein translating further comprises radially compressing the expandable support device, wherein when the expandable support device is partially translated into the sheath, a sheathed portion of the expandable support device has a first diameter and a non-sheathed portion of the expandable support device has a second diameter, and wherein the first diameter is less than the second diameter.
  • 14. The method of claim 12, further comprising translating the expandable support device out of the bone, wherein when the device is in the fully contracted configuration, a straight axis perpendicular to the device longitudinal axis intersects the device longitudinal axis, an apex of the helical ridge, and a surface of the first strut opposite the apex of the helical ridge.
  • 15. The method of claim 12, wherein the expandable support device comprises a first cell and a second cell.
  • 16. The method of claim 12, wherein the helical ridge extends radially outward relative to the device longitudinal axis, wherein the expandable support device has a third strut and a fourth strut, and wherein the third and fourth struts are connected to the first strut second end.
  • 17. A method of retrieving a deployed expandable support device from a bone, wherein the deployed expandable support device is in a radially expanded configuration, and wherein the expandable support device has pushed through a portion of the bone, comprising: expanding an expandable length of the expandable support device in the bone with a deployer engaged with a key, wherein the expandable support device has a circular cross-section before the expanding of the expandable support device in the bone, and wherein when the device is in a contracted configuration, an outer diameter of a proximal terminal end of the device is less than an outer diameter of a longitudinally medial portion of the device;attaching to the expandable support device, wherein the expandable support device is fixed in the bone at least by pressing a first strut having a first ridge, a second strut having a second ridge, a third strut having a third ridge, and a fourth strut having a fourth ridge of the expandable support device into the bone, wherein the first strut has a first strut first end and a first strut second end, wherein the second strut has a second strut first end and a second strut second end, wherein the third strut has a third strut first end and a third strut second end, wherein the fourth strut has a fourth strut first end and a fourth strut second end, wherein the first strut first end and the fourth strut first end are connected to each other, wherein the first strut second end is connected to the second strut first end, wherein the fourth strut second end is connected to the third strut first end, wherein the second strut second end and the third strut second end are connected to each other, wherein when the device is in a fully radially expanded configuration, the first, second, third, and fourth struts define a first cell in the longitudinally medial portion of the device, wherein the first ridge extends radially outward relative to the proximal terminal end of the device when the device is in the fully radially expanded configuration, wherein the first ridge is a portion of a first helical ridge of the expandable length, wherein the first helical ridge is defined by first and second edges angled relative to one another, wherein when the device is in the fully radially expanded configuration, the first ridge defines a radial outermost point of the device, wherein when the device is in a fully radially contracted configuration, the expandable length has a second helical ridge extending radially inward, and wherein when the device is in the fully radially contracted configuration, the first strut comprises a variable cross-section long a length of the first strut, and wherein the variable cross-section is perpendicular to a device longitudinal axis;holding the expandable support device; andtranslating the expandable support device into a sheath, wherein translating the expandable support device comprises longitudinally tensioning the expandable support device and radially contracting the expandable support device.
  • 18. The method of claim 17, wherein the sheath comprises a rigid sheath, and wherein the holding comprises holding a first end of the expandable support device, wherein translating further comprises radially compressing the expandable support device, wherein when the expandable support device is partially translated into the sheath, an outer diameter of a longitudinally medial portion of the expandable support device is greater than a sheath outer diameter, and wherein when the device is in the fully radially contracted configuration, a straight axis perpendicular to the device longitudinal axis intersects the device longitudinal axis, an apex of the first helical ridge, and a surface of the first strut opposite the apex of the first helical ridge.
  • 19. The method of claim 17, further comprising translating the expandable support device out of the bone.
  • 20. The method of claim 17, wherein the expandable support device comprises a second cell, wherein the second, third, and fourth ridges extend radially outward relative to the proximal terminal end of the device when the device is in the fully radially expanded configuration, and wherein when the device is in the fully radially expanded configuration, the first cell is a radial outermost cell of the device.
  • 21. The method of claim 17, wherein a distal terminal end of the expandable length tapers radially inward, wherein the second ridge extends radially outward relative to the proximal terminal end of the device when the device is in the fully radially expanded configuration, wherein the third and fourth ridges extend inward relative to the proximal terminal end of the device when the device is in the fully radially expanded configuration, and wherein when the device is in the fully radially expanded configuration, the first cell is a radial outermost cell of the device.
  • 22. The method of claim 17, wherein the first helical ridge extends radially outward relative to the device longitudinal axis.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of PCT International Application No. PCT/US2007/067967, filed May 1, 2007, which claims the benefit of U.S. Provisional Application No. 60/796,915, filed May 1, 2006, which are herein incorporated by reference in their entireties.

US Referenced Citations (662)
Number Name Date Kind
646119 Clamer et al. Mar 1900 A
4204531 Aginsky May 1980 A
4541423 Barber Sep 1985 A
4569338 Edwards Feb 1986 A
4636217 Ogilvie et al. Jan 1987 A
4653489 Tronzo Mar 1987 A
4716839 Catena Jan 1988 A
4716893 Fischer et al. Jan 1988 A
4725264 Glassman Feb 1988 A
4733665 Palmaz Mar 1988 A
4759769 Hedman et al. Jul 1988 A
4763644 Webb Aug 1988 A
4863476 Sheppard Sep 1989 A
4886062 Wiktor Dec 1989 A
4911718 Lee et al. Mar 1990 A
4932975 Main et al. Jun 1990 A
4941466 Romano Jul 1990 A
4969888 Scholten et al. Nov 1990 A
5007909 Rogozinski Apr 1991 A
5015247 Michelson May 1991 A
5026373 Ray et al. Jun 1991 A
5059193 Kuslich Oct 1991 A
5108404 Scholten et al. Apr 1992 A
5123926 Pisharodi Jun 1992 A
5139480 Hickle et al. Aug 1992 A
5171278 Pisharodi Dec 1992 A
5192327 Brantigan Mar 1993 A
5217483 Tower Jun 1993 A
5258031 Sallb et al. Nov 1993 A
5306278 Dahl et al. Apr 1994 A
5324295 Shapiro, III Jun 1994 A
5342348 Kaplan Aug 1994 A
5345927 Bonutti Sep 1994 A
5390683 Pisharodi Feb 1995 A
5390898 Smedley et al. Feb 1995 A
5397364 Kozak et al. Mar 1995 A
5425773 Boyd et al. Jun 1995 A
5454365 Bonutti Oct 1995 A
5458643 Oka et al. Oct 1995 A
5480442 Bertagnoli Jan 1996 A
5484384 Fearnot Jan 1996 A
5496365 Sgro Mar 1996 A
5522899 Michelson Jun 1996 A
5534002 Brumfield et al. Jul 1996 A
5540690 Miller et al. Jul 1996 A
5549679 Kuslich Aug 1996 A
5554191 Lahille et al. Sep 1996 A
5556413 Lam Sep 1996 A
5562736 Ray et al. Oct 1996 A
5562738 Boyd et al. Oct 1996 A
5571189 Kuslich Nov 1996 A
5571192 Schonhoffer Nov 1996 A
5584831 McKay Dec 1996 A
5591197 Orth et al. Jan 1997 A
5593409 Michelson Jan 1997 A
5609356 Mossi Mar 1997 A
5609635 Michelson Mar 1997 A
5643264 Sherman et al. Jul 1997 A
5643312 Fischell et al. Jul 1997 A
5645560 Crocker et al. Jul 1997 A
5649950 Bourne et al. Jul 1997 A
5653763 Errico et al. Aug 1997 A
5658335 Allen Aug 1997 A
5665122 Kambin Sep 1997 A
5669909 Zdeblick et al. Sep 1997 A
5674295 Ray et al. Oct 1997 A
5683394 Rinner Nov 1997 A
5693100 Pisharodi Dec 1997 A
5702449 McKay Dec 1997 A
5702453 Rabbe et al. Dec 1997 A
5741253 Michelson Apr 1998 A
5749916 Richelsoph May 1998 A
5772661 Michelson Jun 1998 A
5776181 Lee et al. Jul 1998 A
5776197 Rabbe et al. Jul 1998 A
5776198 Rabbe Jul 1998 A
5776199 Michelson Jul 1998 A
5782832 Larsen et al. Jul 1998 A
5782903 Wiktor Jul 1998 A
5785710 Michelson Jul 1998 A
5800520 Fogarty et al. Sep 1998 A
5824054 Khosravi et al. Oct 1998 A
5824093 Ray et al. Oct 1998 A
5827289 Reiley et al. Oct 1998 A
5827321 Roubin et al. Oct 1998 A
5853419 Imran Dec 1998 A
5861025 Boudghene et al. Jan 1999 A
5863284 Klein Jan 1999 A
5865848 Baker Feb 1999 A
5895387 Guerrero et al. Apr 1999 A
5902475 Trozera et al. May 1999 A
5972015 Scribner et al. Oct 1999 A
5980522 Koros et al. Nov 1999 A
5980550 Eder et al. Nov 1999 A
5984957 Laptewicz et al. Nov 1999 A
5993483 Gianotti Nov 1999 A
6001130 Bryan et al. Dec 1999 A
6019765 Thornhill et al. Feb 2000 A
6019792 Cauthen Feb 2000 A
6022376 Assell et al. Feb 2000 A
6025104 Fuller et al. Feb 2000 A
6027527 Asano et al. Feb 2000 A
6036719 Meilus Mar 2000 A
6039761 Li et al. Mar 2000 A
6045579 Hochshuler et al. Apr 2000 A
6053916 Moore Apr 2000 A
6066154 Reiley et al. May 2000 A
6077246 Kullas et al. Jun 2000 A
6080158 Lin Jun 2000 A
6080193 Hochshuler et al. Jun 2000 A
6083522 Chu et al. Jul 2000 A
6086610 Duerig et al. Jul 2000 A
6090143 Meriwether et al. Jul 2000 A
6102619 Truebe et al. Aug 2000 A
6102950 Vaccaro Aug 2000 A
6113639 Ray et al. Sep 2000 A
6126689 Brett Oct 2000 A
6127597 Beyar et al. Oct 2000 A
6129763 Chauvin et al. Oct 2000 A
6132465 Ray et al. Oct 2000 A
6140452 Felt et al. Oct 2000 A
6146417 Ischinger Nov 2000 A
6159244 Suddaby Dec 2000 A
6159245 Meriwether et al. Dec 2000 A
6168616 Brown, III Jan 2001 B1
6171312 Beaty Jan 2001 B1
6176882 Biedermann et al. Jan 2001 B1
6179874 Cauthen Jan 2001 B1
6183506 Penn et al. Feb 2001 B1
6183517 Suddaby Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6206910 Berry et al. Mar 2001 B1
6206924 Timm Mar 2001 B1
6224595 Michelson May 2001 B1
6224603 Marino May 2001 B1
6224604 Suddaby May 2001 B1
6224607 Michelson May 2001 B1
6235043 Reiley et al. May 2001 B1
6241734 Scribner et al. Jun 2001 B1
6245101 Drasler et al. Jun 2001 B1
6245107 Ferree Jun 2001 B1
6248110 Reiley et al. Jun 2001 B1
6280456 Scribner et al. Aug 2001 B1
6287332 Bolz et al. Sep 2001 B1
6293967 Shanley Sep 2001 B1
6296644 Saurat et al. Oct 2001 B1
6302914 Michelson Oct 2001 B1
6332895 Suddaby Dec 2001 B1
6371989 Chauvin et al. Apr 2002 B1
6387130 Stone et al. May 2002 B1
6395031 Foley et al. May 2002 B1
6402750 Atkinson et al. Jun 2002 B1
6402785 Zdeblick et al. Jun 2002 B1
6409765 Bianchi et al. Jun 2002 B1
6419704 Ferree Jul 2002 B1
6419705 Erickson Jul 2002 B1
6423083 Reiley et al. Jul 2002 B2
6425916 Garrison et al. Jul 2002 B1
6425919 Lambrecht Jul 2002 B1
6428569 Brown Aug 2002 B1
6432107 Ferree Aug 2002 B1
6436098 Michelson Aug 2002 B1
6436140 Liu et al. Aug 2002 B1
6440168 Cauthen Aug 2002 B1
6447544 Michelson Sep 2002 B1
6447546 Bramlet et al. Sep 2002 B1
6447547 Michelson Sep 2002 B1
6451025 Jervis Sep 2002 B1
6454804 Ferree Sep 2002 B1
6468301 Amplatz et al. Oct 2002 B1
6468302 Cox et al. Oct 2002 B2
6475237 Drasler et al. Nov 2002 B2
6478823 Michelson Nov 2002 B1
6482235 Lambrecht et al. Nov 2002 B1
6488710 Besselink Dec 2002 B2
6491724 Ferree Dec 2002 B1
6494883 Ferree Dec 2002 B1
6508820 Bales Jan 2003 B2
6508839 Lambrecht et al. Jan 2003 B1
6514255 Ferree Feb 2003 B1
6520991 Huene Feb 2003 B2
6533817 Norton et al. Mar 2003 B1
6554833 Levy et al. Apr 2003 B2
6562074 Gerbec et al. May 2003 B2
6582431 Ray Jun 2003 B1
6582467 Teitelbaum et al. Jun 2003 B1
6585770 White et al. Jul 2003 B1
6592589 Hajianpour Jul 2003 B2
6592625 Cauthen Jul 2003 B2
6595998 Johnson et al. Jul 2003 B2
6602291 Ray et al. Aug 2003 B1
6607530 Carl et al. Aug 2003 B1
6607544 Boucher et al. Aug 2003 B1
6613054 Scribner et al. Sep 2003 B2
6623505 Scribner et al. Sep 2003 B2
6641587 Scribner et al. Nov 2003 B2
6641614 Wagner et al. Nov 2003 B1
6645213 Sand et al. Nov 2003 B2
6645247 Ferree Nov 2003 B2
6648917 Gerbec et al. Nov 2003 B2
6648918 Ferree Nov 2003 B2
6648920 Ferree Nov 2003 B2
6652584 Michelson Nov 2003 B2
6656178 Veldhuizen et al. Dec 2003 B1
6663647 Reiley et al. Dec 2003 B2
6666891 Boehm, Jr. et al. Dec 2003 B2
6676665 Foley et al. Jan 2004 B2
6679915 Cauthen Jan 2004 B1
6685695 Ferree Feb 2004 B2
6695760 Winkler et al. Feb 2004 B1
6706068 Ferree Mar 2004 B2
6706070 Wagner et al. Mar 2004 B1
6709458 Michelson Mar 2004 B2
6712853 Kuslich Mar 2004 B2
6716216 Boucher et al. Apr 2004 B1
6716247 Michelson Apr 2004 B2
6719773 Boucher et al. Apr 2004 B1
6723126 Berry Apr 2004 B1
6726691 Osorio et al. Apr 2004 B2
6733535 Michelson May 2004 B2
6736818 Perren et al. May 2004 B2
6740090 Cragg et al. May 2004 B1
6743255 Ferree Jun 2004 B2
6746451 Middleton et al. Jun 2004 B2
6758863 Estes et al. Jul 2004 B2
6793656 Mathews Sep 2004 B1
6793679 Michelson Sep 2004 B2
6808537 Michelson Oct 2004 B2
6814756 Michelson Nov 2004 B1
6830589 Erickson Dec 2004 B2
6852115 Kinnett Feb 2005 B2
6852123 Brown Feb 2005 B2
6852129 Gerbec et al. Feb 2005 B2
6863673 Gerbec et al. Mar 2005 B2
6893464 Kiester May 2005 B2
6899716 Cragg May 2005 B2
6899719 Reiley et al. May 2005 B2
6921264 Mayer et al. Jul 2005 B2
6923813 Phillips et al. Aug 2005 B2
6923830 Michelson Aug 2005 B2
6936065 Khan et al. Aug 2005 B2
6936070 Muhanna Aug 2005 B1
6948223 Shortt Sep 2005 B2
6953477 Berry Oct 2005 B2
6955691 Chae et al. Oct 2005 B2
6960215 Olson et al. Nov 2005 B2
6962606 Michelson Nov 2005 B2
6981981 Reiley et al. Jan 2006 B2
6988710 Igarashi Jan 2006 B2
7008453 Michelson Mar 2006 B1
7018415 McKay Mar 2006 B1
7018416 Hanson et al. Mar 2006 B2
7056321 Pagliuca et al. Jun 2006 B2
7060073 Frey et al. Jun 2006 B2
7066961 Michelson Jun 2006 B2
7077864 Byrd et al. Jul 2006 B2
7087055 Lim et al. Aug 2006 B2
7094257 Mujwid et al. Aug 2006 B2
7097648 Globerman et al. Aug 2006 B1
7112206 Michelson Sep 2006 B2
7118598 Michelson Oct 2006 B2
7135043 Nakahara et al. Nov 2006 B2
7166110 Yundt Jan 2007 B2
7201751 Zucherman et al. Apr 2007 B2
7201775 Gorensek et al. Apr 2007 B2
7204853 Gordon et al. Apr 2007 B2
7211112 Baynham et May 2007 B2
7212480 Shoji et al. May 2007 B2
7223292 Messerli et al. May 2007 B2
7226475 Lenz et al. Jun 2007 B2
7226481 Kuslich Jun 2007 B2
7226483 Gerber et al. Jun 2007 B2
7238186 Zdeblick et al. Jul 2007 B2
7241297 Shaolian et al. Jul 2007 B2
7241303 Reiss et al. Jul 2007 B2
7300440 Zdeblick et al. Nov 2007 B2
7309338 Cragg Dec 2007 B2
7311713 Johnson et al. Dec 2007 B2
7316714 Gordon et al. Jan 2008 B2
7318826 Teitelbaum et al. Jan 2008 B2
7396360 Lieberman Jul 2008 B2
7431735 Liu et al. Oct 2008 B2
7452371 Pavcnik et al. Nov 2008 B2
7488337 Saab Feb 2009 B2
7503933 Michelson Mar 2009 B2
7507241 Levy et al. Mar 2009 B2
7582106 Teitelbaum et al. Sep 2009 B2
7601172 Segal et al. Oct 2009 B2
7618457 Hudgins Nov 2009 B2
7621950 Globerman et al. Nov 2009 B1
7625395 Muckter Dec 2009 B2
7628807 Flanagan Dec 2009 B2
7722674 Grotz May 2010 B1
7749228 Lieberman Jul 2010 B2
7763028 Lim et al. Jul 2010 B2
7828849 Lim Nov 2010 B2
7837734 Zucherman et al. Nov 2010 B2
7846206 Oglaza et al. Dec 2010 B2
7867233 Shaolian et al. Jan 2011 B2
7875035 Boucher et al. Jan 2011 B2
7879082 Brown Feb 2011 B2
8007498 Mische Aug 2011 B2
8034110 Garner et al. Oct 2011 B2
8105382 Olmos et al. Jan 2012 B2
8142507 McGuckin Mar 2012 B2
8162943 Justin et al. Apr 2012 B2
8206423 Siegal Jun 2012 B2
8262737 Bagga et al. Sep 2012 B2
8425570 Reiley Apr 2013 B2
8465524 Siegal Jun 2013 B2
8486149 Saidha et al. Jul 2013 B2
8512408 Miller et al. Aug 2013 B2
8535380 Greenhalgh et al. Sep 2013 B2
8579912 Isaza et al. Nov 2013 B2
8672968 Stone et al. Mar 2014 B2
8672977 Siegal et al. Mar 2014 B2
8709042 Greenhalgh et al. Apr 2014 B2
8777993 Siegal et al. Jul 2014 B2
9050112 Greenhalgh et al. Jun 2015 B2
9149286 Greenhalgh et al. Oct 2015 B1
9259329 Greenhalgh et al. Feb 2016 B2
9314349 Greenhalgh et al. Apr 2016 B2
9510885 Burger et al. Dec 2016 B2
9770339 Greenhalgh et al. Sep 2017 B2
10070968 Greenhalgh et al. Sep 2018 B2
10285819 Greenhalgh May 2019 B2
10285820 Greenhalgh May 2019 B2
10292828 Greenhalgh May 2019 B2
20010007956 Letac et al. Jul 2001 A1
20010034552 Young et al. Oct 2001 A1
20020007218 Cauthen Jan 2002 A1
20020010511 Michelson Jan 2002 A1
20020022887 Huene Feb 2002 A1
20020032444 Mische Mar 2002 A1
20020038767 Trozera Apr 2002 A1
20020052656 Michelson May 2002 A1
20020068911 Chan Jun 2002 A1
20020068939 Levy et al. Jun 2002 A1
20020068975 Teitelbaum et al. Jun 2002 A1
20020068976 Jackson Jun 2002 A1
20020068977 Jackson Jun 2002 A1
20020082598 Teitelbaum Jun 2002 A1
20020082600 Shaolian et al. Jun 2002 A1
20020091390 Michelson Jul 2002 A1
20020095155 Michelson Jul 2002 A1
20020099378 Michelson Jul 2002 A1
20020111688 Cauthen Aug 2002 A1
20020120337 Cauthen Aug 2002 A1
20020123807 Cauthen Sep 2002 A1
20020128713 Ferree Sep 2002 A1
20020138077 Ferree Sep 2002 A1
20020138133 Lenz et al. Sep 2002 A1
20020138144 Michelson Sep 2002 A1
20020143401 Michelson Oct 2002 A1
20020151896 Ferree Oct 2002 A1
20020151980 Cauthen Oct 2002 A1
20020156530 Lambrecht et al. Oct 2002 A1
20020161367 Ferree Oct 2002 A1
20020161373 Osorio et al. Oct 2002 A1
20020165542 Ferree Nov 2002 A1
20020189622 Cauthen et al. Dec 2002 A1
20020198526 Shaolian et al. Dec 2002 A1
20030004511 Ferree Jan 2003 A1
20030004574 Ferree Jan 2003 A1
20030009227 Lambrecht et al. Jan 2003 A1
20030014118 Lambrecht et al. Jan 2003 A1
20030026788 Ferree Feb 2003 A1
20030032963 Reiss et al. Feb 2003 A1
20030040796 Ferree Feb 2003 A1
20030040798 Michelson Feb 2003 A1
20030050701 Michelson Mar 2003 A1
20030065394 Michelson Apr 2003 A1
20030065396 Michelson Apr 2003 A1
20030074076 Ferree et al. Apr 2003 A1
20030078579 Ferree Apr 2003 A1
20030088249 Furderer May 2003 A1
20030120345 Cauthen Jun 2003 A1
20030125748 Li et al. Jul 2003 A1
20030125807 Lambrecht et al. Jul 2003 A1
20030135220 Cauthen Jul 2003 A1
20030135279 Michelson Jul 2003 A1
20030149482 Michelson Aug 2003 A1
20030153976 Cauthen et al. Aug 2003 A1
20030158553 Michelson Aug 2003 A1
20030158604 Cauthen et al. Aug 2003 A1
20030163200 Cauthen Aug 2003 A1
20030171813 Kiester Sep 2003 A1
20030181979 Ferree Sep 2003 A1
20030181980 Berry et al. Sep 2003 A1
20030181983 Cauthen Sep 2003 A1
20030187507 Cauthen Oct 2003 A1
20030187508 Cauthen Oct 2003 A1
20030191536 Ferree Oct 2003 A1
20030195514 Trieu et al. Oct 2003 A1
20030195630 Ferree Oct 2003 A1
20030195631 Ferree Oct 2003 A1
20030199979 McGuckin Oct 2003 A1
20030199981 Ferree Oct 2003 A1
20030204189 Cragg Oct 2003 A1
20030204260 Ferree Oct 2003 A1
20030208270 Michelson Nov 2003 A9
20030220643 Ferree Nov 2003 A1
20030220650 Major et al. Nov 2003 A1
20030220690 Cauthen Nov 2003 A1
20030220693 Cauthen Nov 2003 A1
20030220694 Cauthen Nov 2003 A1
20030233097 Ferree Dec 2003 A1
20030233148 Ferree Dec 2003 A1
20030233188 Jones Dec 2003 A1
20030236520 Lim et al. Dec 2003 A1
20040002759 Ferree Jan 2004 A1
20040002760 Boyd et al. Jan 2004 A1
20040002769 Ferree Jan 2004 A1
20040006341 Shaolian et al. Jan 2004 A1
20040006344 Nguyen et al. Jan 2004 A1
20040010315 Song Jan 2004 A1
20040010318 Ferree Jan 2004 A1
20040019386 Ferree Jan 2004 A1
20040024400 Michelson Feb 2004 A1
20040024459 Ferree Feb 2004 A1
20040024460 Ferree Feb 2004 A1
20040024461 Ferree Feb 2004 A1
20040024462 Ferree et al. Feb 2004 A1
20040024469 Ferree Feb 2004 A1
20040024471 Ferree Feb 2004 A1
20040028718 Ferree Feb 2004 A1
20040030387 Landry et al. Feb 2004 A1
20040030389 Ferree Feb 2004 A1
20040030390 Ferree Feb 2004 A1
20040030391 Ferree Feb 2004 A1
20040030398 Ferree Feb 2004 A1
20040034357 Beane et al. Feb 2004 A1
20040044410 Ferree et al. Mar 2004 A1
20040049289 Tordy et al. Mar 2004 A1
20040059418 McKay et al. Mar 2004 A1
20040059419 Michelson Mar 2004 A1
20040059429 Amin et al. Mar 2004 A1
20040068259 Michelson Apr 2004 A1
20040082954 Teitelbaum et al. Apr 2004 A1
20040082961 Teitelbaum Apr 2004 A1
20040087947 Lim et al. May 2004 A1
20040087950 Teitelbaum May 2004 A1
20040092933 Shaolian et al. May 2004 A1
20040092946 Bagga May 2004 A1
20040092988 Shaolian et al. May 2004 A1
20040097927 Yeung et al. May 2004 A1
20040102848 Michelson May 2004 A1
20040111108 Farnan Jun 2004 A1
20040133229 Lambrecht et al. Jul 2004 A1
20040133280 Trieu Jul 2004 A1
20040138673 Lambrecht et al. Jul 2004 A1
20040153064 Foley et al. Aug 2004 A1
20040153065 Lim Aug 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040167625 Beyar et al. Aug 2004 A1
20040172019 Ferree Sep 2004 A1
20050010292 Carrasco Jan 2005 A1
20050015152 Sweeney Jan 2005 A1
20050022839 Savas et al. Feb 2005 A1
20050033431 Gordon et al. Feb 2005 A1
20050038512 Michelson Feb 2005 A1
20050043796 Grant et al. Feb 2005 A1
20050070911 Carrison et al. Mar 2005 A1
20050080422 Otte et al. Apr 2005 A1
20050085910 Sweeney Apr 2005 A1
20050107863 Brown May 2005 A1
20050113919 Cragg et al. May 2005 A1
20050113928 Cragg et al. May 2005 A1
20050119561 Kienzle Jun 2005 A1
20050143827 Globerman et al. Jun 2005 A1
20050182463 Hunter et al. Aug 2005 A1
20050187558 Johnson et al. Aug 2005 A1
20050209698 Gordon et al. Sep 2005 A1
20050228391 Levy et al. Oct 2005 A1
20050228472 Case et al. Oct 2005 A1
20050240188 Chow et al. Oct 2005 A1
20050249776 Chen et al. Nov 2005 A1
20050261683 Veldhuizen et al. Nov 2005 A1
20050261695 Cragg et al. Nov 2005 A1
20050261768 Trieu Nov 2005 A1
20050261781 Sennett et al. Nov 2005 A1
20050278023 Zwirkoski Dec 2005 A1
20050278026 Gordon et al. Dec 2005 A1
20050278036 Leonard et al. Dec 2005 A1
20060004455 Leonard et al. Jan 2006 A1
20060015184 Winterbottom et al. Jan 2006 A1
20060022180 Selness Feb 2006 A1
20060036241 Siegal Feb 2006 A1
20060036273 Siegal Feb 2006 A1
20060052788 Thelen et al. Mar 2006 A1
20060052870 Ferree Mar 2006 A1
20060058807 Landry et al. Mar 2006 A1
20060058876 McKinley Mar 2006 A1
20060058880 Wysocki et al. Mar 2006 A1
20060079898 Ainsworth et al. Apr 2006 A1
20060085069 Kim Apr 2006 A1
20060085070 Kim Apr 2006 A1
20060089715 Truckai et al. Apr 2006 A1
20060095123 Flanagan May 2006 A1
20060100706 Shadduck May 2006 A1
20060106460 Messerli et al. May 2006 A1
20060122701 Kiester Jun 2006 A1
20060129244 Ensign Jun 2006 A1
20060142858 Colleran et al. Jun 2006 A1
20060142859 McLuen Jun 2006 A1
20060149239 Winslow et al. Jul 2006 A1
20060149349 Garbe Jul 2006 A1
20060149385 McKay Jul 2006 A1
20060155379 Heneveld et al. Jul 2006 A1
20060161261 Brown et al. Jul 2006 A1
20060178694 Greenhalgh et al. Aug 2006 A1
20060184188 Li et al. Aug 2006 A1
20060184248 Edidin Aug 2006 A1
20060189999 Zwirkoski Aug 2006 A1
20060200166 Hanson et al. Sep 2006 A1
20060206207 Dryer et al. Sep 2006 A1
20060235414 Lim et al. Oct 2006 A1
20060235423 Cantu Oct 2006 A1
20060241764 Michelson Oct 2006 A1
20060253201 McLuen Nov 2006 A1
20060264968 Frey et al. Nov 2006 A1
20060265077 Zwirkoski Nov 2006 A1
20060271061 Beyar et al. Nov 2006 A1
20060287725 Miller Dec 2006 A1
20060287726 Segal et al. Dec 2006 A1
20060287727 Segal et al. Dec 2006 A1
20060287729 Segal et al. Dec 2006 A1
20060287730 Segal et al. Dec 2006 A1
20070027363 Gannoe et al. Feb 2007 A1
20070032791 Greenhalgh Feb 2007 A1
20070043440 William Feb 2007 A1
20070055201 Seto Mar 2007 A1
20070055375 Ferree Mar 2007 A1
20070055377 Hanson et al. Mar 2007 A1
20070067034 Chirico et al. Mar 2007 A1
20070067035 Falahee Mar 2007 A1
20070093897 Gerbec et al. Apr 2007 A1
20070093899 Dutoit et al. Apr 2007 A1
20070112428 Lancial May 2007 A1
20070118222 Lang May 2007 A1
20070123877 Goldin May 2007 A1
20070123986 Schaller May 2007 A1
20070162044 Marino Jul 2007 A1
20070162135 Segal et al. Jul 2007 A1
20070173824 Rosen Jul 2007 A1
20070173830 Rosen Jul 2007 A1
20070173939 Kim Jul 2007 A1
20070173940 Hestad et al. Jul 2007 A1
20070208423 Messerli et al. Sep 2007 A1
20070213717 Trieu et al. Sep 2007 A1
20070219634 Greenhalgh et al. Sep 2007 A1
20070225703 Schmitz et al. Sep 2007 A1
20070233260 Cragg Oct 2007 A1
20070239162 Bhatnagar et al. Oct 2007 A1
20070244485 Greenhalgh et al. Oct 2007 A1
20070255408 Castleman et al. Nov 2007 A1
20070255409 Dickson et al. Nov 2007 A1
20070260270 Assell et al. Nov 2007 A1
20070260315 Foley et al. Nov 2007 A1
20070270956 Heinz Nov 2007 A1
20070270968 Baynham et al. Nov 2007 A1
20070276377 Yundt Nov 2007 A1
20070276382 Mikhail et al. Nov 2007 A1
20070282342 Niederberger et al. Dec 2007 A1
20070288028 Gorensek et al. Dec 2007 A1
20080015694 Tribus Jan 2008 A1
20080021558 Thramann Jan 2008 A1
20080021559 Thramann Jan 2008 A1
20080071356 Greenhalgh et al. Mar 2008 A1
20080077150 Nguyen Mar 2008 A1
20080082162 Boismier et al. Apr 2008 A1
20080124865 Lutze et al. May 2008 A1
20080125864 De Villiers et al. May 2008 A1
20080125865 Abdelgany May 2008 A1
20080133012 McGuckin Jun 2008 A1
20080140082 Erdem et al. Jun 2008 A1
20080140179 Ladisa Jun 2008 A1
20080140207 Olmos et al. Jun 2008 A1
20080147193 Matthis et al. Jun 2008 A1
20080147194 Grotz et al. Jun 2008 A1
20080183204 Greenhalgh et al. Jul 2008 A1
20080188941 Grotz Aug 2008 A1
20080208255 Siegal Aug 2008 A1
20080221687 Viker Sep 2008 A1
20080243255 Butler et al. Oct 2008 A1
20080249625 Butler Oct 2008 A1
20080249628 Altarac et al. Oct 2008 A1
20080281346 Greenhalgh et al. Nov 2008 A1
20080294205 Greenhalgh et al. Nov 2008 A1
20080312744 Vresilovic et al. Dec 2008 A1
20090005871 White et al. Jan 2009 A1
20090012564 Chirico et al. Jan 2009 A1
20090018524 Greenhalgh et al. Jan 2009 A1
20090024204 Greenhalgh et al. Jan 2009 A1
20090024217 Levy et al. Jan 2009 A1
20090076511 Osman Mar 2009 A1
20090143859 McClellan et al. Jun 2009 A1
20090163918 Levy et al. Jun 2009 A1
20090177207 Schaller Jul 2009 A1
20090182431 Butler et al. Jul 2009 A1
20090198338 Phan Aug 2009 A1
20090234398 Chirico et al. Sep 2009 A1
20090240335 Arcenio et al. Sep 2009 A1
20090292323 Chirico et al. Nov 2009 A1
20090299378 Knopp Dec 2009 A1
20090318928 Purcell et al. Dec 2009 A1
20100004750 Segal et al. Jan 2010 A1
20100004751 Segal et al. Jan 2010 A1
20100016905 Greenhalgh et al. Jan 2010 A1
20100082109 Greenhalgh et al. Apr 2010 A1
20100125274 Greenhalgh et al. May 2010 A1
20100168748 Knopp et al. Jul 2010 A1
20100168862 Edie et al. Jul 2010 A1
20100191336 Greenhalgh Jul 2010 A1
20100211176 Greenhalgh Aug 2010 A1
20100262147 Siegal et al. Oct 2010 A1
20110009869 Marino et al. Jan 2011 A1
20110009969 Puno Jan 2011 A1
20110029083 Hynes et al. Feb 2011 A1
20110046737 Teisen Feb 2011 A1
20110054621 Lim et al. Mar 2011 A1
20110106260 Laurence et al. May 2011 A1
20110118785 Reiley May 2011 A1
20110125266 Rodgers et al. May 2011 A1
20110153019 Siegal Jun 2011 A1
20110166575 Assell et al. Jul 2011 A1
20110218626 Krinke et al. Sep 2011 A1
20110230884 Mantzaris et al. Sep 2011 A1
20110230966 Trieu Sep 2011 A1
20110282398 Overes et al. Nov 2011 A1
20110282453 Greenhalgh et al. Nov 2011 A1
20110319898 O'Neil et al. Dec 2011 A1
20110320000 O'Neil et al. Dec 2011 A1
20120004726 Greenhalgh et al. Jan 2012 A1
20120004731 Viker Jan 2012 A1
20120029518 Blackwell et al. Feb 2012 A1
20120071980 Purcell et al. Mar 2012 A1
20130035723 Donner Feb 2013 A1
20130053852 Greenhalgh et al. Feb 2013 A1
20130085535 Greenhalgh et al. Apr 2013 A1
20130138214 Greenhalgh et al. May 2013 A1
20130304224 Schmidt et al. Nov 2013 A1
20140088713 Greenhalgh et al. Mar 2014 A1
20150230931 Greenhalgh Aug 2015 A1
20150265417 Greenhalgh et al. Sep 2015 A1
20150351930 Greenhalgh et al. Dec 2015 A1
20160022429 Greenhalgh et al. Jan 2016 A1
20160058572 Greenhalgh et al. Mar 2016 A1
20160310291 Greenhalgh Oct 2016 A1
20160374727 Greenhalgh et al. Dec 2016 A1
20170119540 Greenhalgh May 2017 A1
20170119541 Greenhalgh May 2017 A1
20170165083 Greenhalgh Jun 2017 A1
20170181865 Greenhalgh et al. Jun 2017 A1
20170196613 Greenhalgh et al. Jul 2017 A1
20170319353 Greenhalgh et al. Nov 2017 A1
20170348115 Greenhalgh et al. Dec 2017 A1
20180256359 Greenhalgh Sep 2018 A1
20180368986 Greenhalgh et al. Dec 2018 A1
20190231549 Greenhalgh et al. Aug 2019 A1
20190240043 Greenhalgh Aug 2019 A1
20190254714 Greenhalgh et al. Aug 2019 A1
Foreign Referenced Citations (92)
Number Date Country
19710392 Jul 1999 DE
0734702 Oct 1996 EP
0758541 Feb 1997 EP
2874814 Nov 2007 FR
2900814 Nov 2007 FR
2000-210315 Aug 2000 JP
2003-512887 Apr 2003 JP
2004-511297 Apr 2004 JP
2004-531355 Oct 2004 JP
2004-321348 Nov 2004 JP
2012-522961 Sep 2012 JP
662082 May 1979 SU
WO 1988003781 Jun 1988 WO
WO 1992014423 Sep 1992 WO
WO 1995031945 Nov 1995 WO
WO 1996003092 Feb 1996 WO
WO 1997000054 Jan 1997 WO
WO 2000025706 May 2000 WO
WO 20030523 Jun 2000 WO
WO 2000044319 Aug 2000 WO
WO 2000044321 Aug 2000 WO
WO 20011032099 May 2001 WO
WO 2001078625 Oct 2001 WO
WO 2001095838 Dec 2001 WO
WO 2002013700 Feb 2002 WO
WO 2002032347 Apr 2002 WO
WO 2003003943 Jan 2003 WO
WO 2003003951 Jan 2003 WO
WO 2005062900 Jul 2005 WO
WO 2005096975 Oct 2005 WO
WO 2005120400 Dec 2005 WO
WO 2006023514 Mar 2006 WO
WO 2006023671 Mar 2006 WO
WO 2006026425 Mar 2006 WO
WO 2006028971 Mar 2006 WO
WO 2006034396 Mar 2006 WO
WO 2006034436 Mar 2006 WO
WO 2006037013 Apr 2006 WO
WO 2006042334 Apr 2006 WO
WO 2006050500 May 2006 WO
WO 2006060420 May 2006 WO
WO 2006068682 Jun 2006 WO
WO 2006072941 Jul 2006 WO
WO 2006076712 Jul 2006 WO
WO 2006086241 Aug 2006 WO
WO 2006096167 Sep 2006 WO
WO 2006116760 Nov 2006 WO
WO 2006116761 Nov 2006 WO
WO 2006132945 Dec 2006 WO
WO 2007009107 Jan 2007 WO
WO 2007009123 Jan 2007 WO
WO 2007016368 Feb 2007 WO
WO 2007038611 Apr 2007 WO
WO 2007041665 Apr 2007 WO
WO 2007041698 Apr 2007 WO
WO 2007047098 Apr 2007 WO
WO 2007050322 May 2007 WO
WO 2007056433 May 2007 WO
WO 2007062080 May 2007 WO
WO 2007073488 Jun 2007 WO
WO 2007075411 Jul 2007 WO
WO 2007076308 Jul 2007 WO
WO 2007076374 Jul 2007 WO
WO 2007076376 Jul 2007 WO
WO 2007076377 Jul 2007 WO
WO 2007079021 Jul 2007 WO
WO 2007084239 Jul 2007 WO
WO 2007084257 Jul 2007 WO
WO 2007084268 Jul 2007 WO
WO 2007084810 Jul 2007 WO
WO 2007100591 Sep 2007 WO
WO 2007113808 Oct 2007 WO
WO 2007123920 Nov 2007 WO
WO 2007124130 Nov 2007 WO
WO 2007126622 Nov 2007 WO
WO 2007131026 Nov 2007 WO
WO 2007133608 Nov 2007 WO
WO 20071130699 Nov 2007 WO
WO 2007140382 Dec 2007 WO
WO 2008005627 Jan 2008 WO
WO 2008016598 Feb 2008 WO
WO 2008036505 Mar 2008 WO
WO 2008070863 Jun 2008 WO
WO 2009039430 Mar 2009 WO
WO 2009114381 Sep 2009 WO
WO 2010013188 Feb 2010 WO
WO 2010121002 Oct 2010 WO
WO 2011014502 Feb 2011 WO
WO 2011049949 Apr 2011 WO
WO 2011142761 Nov 2011 WO
WO 2012027490 Mar 2012 WO
WO 2013028808 Feb 2013 WO
Non-Patent Literature Citations (14)
Entry
Franklin, I.J. et al., “Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis,” Brit. J. Surger, 86(6):771-775, 1999.
Pyo, R. et al., “Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) Suppresses Development of Experimental Abdominal Aortic Aneurysms,” J. Clinical Investigation,105(11):1641-1649, Jun. 2000.
Tambiah, J. et al., “Provocation of Experimental Aortic Inflammation Mediators and Chlamydia Pneumoniae,” Brit., J. Surgery, 88(7):935-940, Feb. 2001.
Walton, L.J. et al., “Inhibition of Prostaglandin E2 Synthesis in Abdonminal Aortic Aneurysms,” Circulation, 48-54. Jul. 6, 1999.
Xu, Q. et al., “Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium,” J. Biological Chemistry, 275(32):24583-24589, Aug. 2000.
U.S. Appl. No. 11/689,465, filed Mar. 21, 2007.
U.S. Appl. No. 11/689,471, filed Mar. 21, 2007.
U.S. Appl. No. 11/877,610, filed Oct. 23, 2007.
U.S. Appl. No. 13/216,123, filed Aug. 23, 2011.
U.S. Appl. No. 12/693,394, filed Jan. 25, 2010.
U.S. Appl. No. 12/779,865, filed May 13, 2010.
U.S. Appl. No. 13/296,066, filed Nov. 14, 2011.
Database WPI, Week 198004, Thomson Scientific, London, GB; AN 1980-A8866C, XP002690114, -& SU 662 082 A1 (Tartus Univ) May 15, 1979 (May 15, 1979), abstract, figures 1,2.
Choi, G. et al., “Percutaneous Endoscopic Lumbar Discemtomy by Transiliac Approach,” Spine, 34(12):E443-446, May 20, 2009.
Related Publications (1)
Number Date Country
20090149956 A1 Jun 2009 US
Provisional Applications (1)
Number Date Country
60796915 May 2006 US
Continuation in Parts (1)
Number Date Country
Parent PCT/US2007/067967 May 2007 US
Child 12260971 US